Skip to main content
Quest Diagnostics

Cortisol Concentrations in COVID-19 and Influenza: a Comparative Study

ENDO 2025

American Society for Microbiology

San Francisco, CA, July 12-15, 2025

Poster presentation: Cortisol Concentrations in COVID-19 and Influenza: a Comparative Study

Authors: Champion C,Lui M, Wu ZR, McPhaul MJ, Mudd P, Diwan A, Dhindsa S

Medical Specialty: Cardiovascular disease, Endocrinology, Infectious disease, Cardiology

Related content

Conference Presentation
COVID-19 Real World Data infrastructure (CRWDi): A Big Data Resource for Study of Immunocompromised Patient Populations
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Publication
Prevalence and Co-Detection Rates of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus: A Retrospective Analysis
Publication
Cardiometabolic risk increased in working-aged adults during the COVID-19 pandemic
Audio Podcast
Action From Insight: Tackling Insulin Resistance

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.